AHRQ expands network to focus on healthcare issues
The HHS Agency for Healthcare Research and Quality (AHRQ) announcedan award of $16 million over the next five years to establish fournew Centers for Education & Research on Therapeutics (CERTs) toincrease awareness of the benefits and risks of therapeuticproducts, including prescription medicines, biological products,and medical devices, and to translate research findings intoimproved health care. The CERTs are located at Rutgers, the StateUniversity of New Jersey in New Brunswick; the University of Iowa;Baylor College of Medicine in Houston; and Weill Medical College ofCornell University in New York City.
The HHS Agency for Healthcare Research and Quality (AHRQ) announced an award of $16 million over the next five years to establish four new Centers for Education & Research on Therapeutics (CERTs) to increase awareness of the benefits and risks of therapeutic products, including prescription medicines, biological products, and medical devices, and to translate research findings into improved health care. The CERTs are located at Rutgers, the State University of New Jersey in New Brunswick; the University of Iowa; Baylor College of Medicine in Houston; and Weill Medical College of Cornell University in New York City.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
